Optical Genome Mapping Technology Revolutionizing Genomic Research and Clinical Diagnostics

Optical genome mapping market, estimated at $132 million in 2024, is projected to grow to $1.5 billion with a CAGR of 23.9% during the forecast period (2025–2035). Optical genome mapping used in the field of molecular cytogenetics has the potential to replace conventional testing methodologies in clinical diagnostics. The growing adoption of cytogenetic/molecular genetics technologies with improved standard diagnostics is the key factor supporting the growth of the market globally.

Browse the full report description of “Optical Genome Mapping Market Size, Share & Trends Analysis Report By Offerings (Consumables, Instruments, Services, and Software), By Application (Genome Assembly, Structural Variation Detection, Microbial Strain Typing, Haplotype Phasing, and Others (Improving De Novo Plant Genome Assemblies, Identifying Genetic Abnormalities, Diagnosing Non-Haematological Cancers), And By End Users (Research & Academic Institutions, Biotechnology & Pharmaceutical Companies, Clinical Laboratories And Others (CRO)), Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/optical-genome-mapping-market

Revolutionizing Genomic Research and Clinical Diagnostics

• Rising Cancer Prevalence: As with 10 million cancer-related deaths globally in 2024, OGM’s role in identifying therapeutic targets and resistance mechanisms is critical.

• Technological Advancements: Innovations in high-resolution imaging, labeling technologies, and computational analytics are enhancing the precision of optical genome mapping. Manufacturers such as Bionano Genomics and Genomic Vision are at the forefront, continuously refining their systems to deliver faster, more reliable results.

• Rising Demand for Precision Medicine: As healthcare moves toward tailored treatment plans, the ability to detect subtle genetic variations and structural changes becomes paramount. OGM provides the detailed genomic insights required to support personalized healthcare.

Key Players and Innovations

In May 2024, NewBiologix SA, a company, announced the launch of its next-generation sequencing (NGS) and optical mapping platform, a novel suite of technologies combined to offer comprehensive genomic analysis services to the biopharmaceutical industry. This platform integrates the latest advancements in sequencing and genomic mapping technologies, combining the strengths of industry leaders such as Illumina, PacBio, Nanopore, and Bionano.

In January 2024, Bionano Genomics, Inc. announced the full commercial release of the Stratys system, the Company’s system for high-throughput optical genome mapping (OGM). Bionano’s Stratys system offers increased flexibility and throughput capabilities to address the needs of mid and high-volume users. It is compatible and has a potential sample-to-answer time of 3 days for hematological samples interrogated across the whole genome at high sensitivity to rare variants.

Market Coverage

• The market numbers available for – 2024-2035

• Base year- 2024

• Forecast period- 2025-2035

• Segment Covered- 

o By Offerings 

o By Application

o End Users 

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape - Bionano Genomics, Inc., Nabsys, Inc., Illumina, Inc., Thermo Fisher Scientific, Inc., and Others. 

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Optical Genome Mapping Market Report Segment

By Offerings 

• Consumables
• Instruments
• Services, and Software

By Application 

• Genome Assembly
• Structural Variation Detection
• Microbial Strain Typing
• Haplotype Phasing
• other

By End Users

• Research & Academic Institutions
• Biotechnology & Pharmaceutical Companies
• Clinical Laboratories
• Others (CRO)

Global Optical Genome Mapping Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Russia

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Australia and New Zealand

• ASEAN Economies

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/optical-genome-mapping-market